+
Site Tour

Cardiac imaging in AS - conduction system and morphology focus A. Cook

2nd Annual International TAVI Summit

Watch on Demand videos on TAVI Summit 2024

Related Videos

TAVI Summit - Cardiac imaging

TAVI Summit - TAVR in bicuspid

TAVI Summit - Live case from Berlin

TAVI Summit - Cardiac imaging

PremiClose 2024: Risks vs benefits of closure

TAVI 2023: Optimizing TAVI

PremiClose 2024: Neo-Ped Cardio Team

ESC 2023 Tutorial – TriClip™ | Dr. Sanchis

PremiClose 2024: Beside PDA closure

EuroPCR 2023: Defining the future

TAVI Summit - Cardiac imaging

PremiClose 2024: Nenonatologist view

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

TAVI Summit - Live case from Berlin

Navitor™: Voice of the Experts Mohammed Saad

Now you've got Navitor.
Future ready.

Early outcomes on Epic Max platform

CONNEXT


HUB
RELATED RESOURCES

PCR LV 2021: Navitor™ Looking ahead

Epic Mitral – 10-Year Clinical Outcomes

Data Summary PFO closure in patients > 60 Years

AVP III Case compendium

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline